Page 3 - Solution Group Bhd News Today

(Bloomberg) -- Moderna Inc. won approval from Singapore for its Covid vaccine and signed a deal to sell doses to the Philippines, becoming the fourth supplier to get regulatory clearance in Southeast Asia. Shots by AstraZeneca Plc, Pfizer Inc.-BioNTech SE and Sinovac Biotech Ltd.

Pharmaniaga will be the first biggest player in the race of developing its own Malaysian-made halal vaccines by 2024. WITH the vaccine rollout starting to take on more influence throughout the world and even here in Malaysia, it was no surprise that the pace of Malaysia’s own programme has started to flesh out in greater detail. That in turn has seen companies, which have long been entrenched in the healthcare theme, beginning to reveal more developments of their strategies. But more signific...

Its wholly-owned unit Solution Biologics has signed the agreement on Jan 29 with the Health Ministry.

Despite signing a term sheet to supply 3.5 million doses of a Chinese Covid-19 to the Malaysian government, shares in Solution Group Bhd did not receive the expected boost today. Shares in the engineering and biopharmaceuticals company shed as much as 8.72% or 13 sen this morning. At 10.12am, shares in Solution Group were down 7.38% or 11 sen lower at RM1.38, translating into a market value of RM527.25 million.

“The term sheet agreement is to enable Solbio to enter into a definitive agreement to supply 3.5 million doses of the Recombinant Ad5-nCoV vaccine for the prevention of Covid-19. The vaccine is jointly developed by CanSino Biologics Inc and Beijing Institute of Biotechnology, Academy of Military Medical Sciences, ” the company said in a filing with Bursa Malaysia. ’s unit Solution Biologics Sdn Bhd (Solbio) said it has signed a term sheet agreement with the Health Ministry to supply Covid...

路透新闻部 2 分钟阅读 KUALA LUMPUR, Feb 4 (Reuters) - Malaysia’s Solution Group Bhd said on Thursday it has signed a term sheet agreement with the government to supply 3.5 million doses of COVID-19 vaccine jointly developed by China’s CanSino Biologics Inc and Beijing Institute of Biotechnology under the Academy of Military Medical Sciences. The company, whose website shows it is an engineering as well as biopharmaceuticals business, said in a bourse filing that its wholly-owned un...

said wholly-owned subsidiary Solution Biologics Sdn Bhd (SolBio) has signed a term sheet agreement with the Ministry of Health (MoH) for the supply of Covid-19 vaccine. "The term sheet agreement, signed on Jan 29, is to enable SolBio to enter into a definitive supply agreement to supply 3.5 million doses of the Recombinant Ad5-nCoV vaccine," the company said in a filing today. The vaccine, Solution Group said, was jointly developed by CanSino Biologics Inc and Beijing Institute of Biotechnolog...

By Reuters Staff 2 Min Read FILE PHOTO: Woman holds vials labelled "COVID-19 Coronavirus Vaccine" over dry ice in this illustration taken, December 5, 2020. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo KUALA LUMPUR (Reuters) - Malaysia’s Solution Group Bhd said on Thursday it has signed a term sheet agreement with the government to supply 3.5 million doses of COVID-19 vaccine jointly developed by China’s CanSino Biologics Inc and Beijing Institute of Biotechnology under the Academy...

KUALA LUMPUR (Feb 4): Based on corporate announcements and news flow today, companies that may be in focus tomorrow (Friday, Feb 5) include: My EG Services Bhd (MyEG), Solarvest Holdings Bhd, Green Packet Bhd, GHL System Bhd, Solution Group Bhd, Tropicana Corp Bhd, Reservoir Link Energy Bhd, CIMB Group Holdings Bhd and Ranhill Utilities Bhd. My EG Services Bhd ( MyEG) said it will introduce an at-home saliva-based Covid-19 testing service in the Philippines this month — the first of its kind...

Kalamazoo, MI, USA / WKZO | Everything Kalamazoo | 590 AM · 106.9 FM Feb 4, 2021 6:38 AM KUALA LUMPUR (Reuters) - Malaysias Solution Group Bhd said on Thursday it has signed a term sheet agreement with the government to supply 3.5 million doses of COVID-19 vaccine jointly developed by Chinas CanSino Biologics Inc and Beijing Institute of Biotechnology under the Academy of Military Medical Sciences. The company, whose website shows it is an engineering as well as biopharmaceuticals business...